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Introduction: Human papillomavirus (HPV) is the most common sexually transmitted infection. Data reporting ver­
tical transmission of HPV from the mother to the fetus are inconsistent and scant. Vertical transmission may occur 
by hematogenic route (transplacental), or by ascending contamination, or through the birth canal, which may result 
in the dreaded and rare laryngeal papillomatosis. Infected sperm at fertilization is a potential route of infection, too. 
Objective: The objective of the study was to evaluate the rate of vertical transmission of HPV in HPV-positive 
pregnant women to their newborn infants, as well as the risk factors of HPV vertical transmission.
Material and methods: The clinical material was provided by 136 pregnant women, aged 18-45 years. Out of 
this group, 30 (22.05%) women with abnormal Pap test and positive DNA HPV test were prospectively observed. 
Neonatal status, i.e. DNA HPV from the nasopharyngeal smear, was recorded in all infants during the perinatal pe­
riod. The conventional Pap test was performed with the cervix brush in all women. The Bethesda 2011 classification 
system was applied.
Results: An average C Reactive Protein (CRP) concentration in the studied pregnant women was 11.6083 (Std 
Dev -  12.93). The most frequent cytological findings in the cervical smears from the examined women were AS- 
CUS, n=13 (43.3%), then -  LSIL, n=10 (33.3%), HSIL- n=5 (16.7%) and AGC- n=2 (6.7%). In the neonates, the 
presence of LR HPV DNA was detected in 9 cases (30.0%) and HR HPV DNA in 7 cases (23.3%). Fourteen neo­
nates (46.7%) tested HPV DNA negative in the perinatal period.
Conclusions: HPV infection (incidental or chronic) is observed in approximately 22% of pregnant women from the 
Małopolska province. Neonatal HPV infection in HPV-positive women was observed in 53.3% of the subjects. CRP 
concentration > 10 mg/dl in the serum of pregnant women statistically significantly (p 0.001) reduces the risk of 
vertical transmission of HPV from the mother to the fetus.
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Streszczenie
Wstęp: Zakażenie HPV jest najczęstszym zakażeniem przenoszonym drogą płciową (STD). Dane literaturowe do­
tyczące zakażenia wertykalnego HPV z matki na płód są niejednoznaczne i nieliczne. Do zakażenia wertykalnego 
może dochodzić drogą krwionośną (przezłożyskową) lub poprzez zakażenie wstępujące, bądź podczas przecho­
dzenia przez kanał rodny, skutkując rzadko występującym schorzeniem- brodawczakowatością krtani. Potencjalną 
drogę zakażenia może stanowić również zakażone nasienie podczas zapłodnienia.
Cel pracy: Celem niniejszego badania była ocena częstości występowania transmisji wertykalnej HPV 
u HPV-dodatnich kobiet na ich nowo urodzone dzieci, jak i określenie czynników ryzyka wertykalnej transmisji HPV. 
Materiał i metody: Materiał kliniczny stanowiło 136 ciężarnych w wieku 18-45 lat. Z  tej grupy, 30 (22,05%) kobiet 
z nieprawidłowym wynikiem badania cytologicznego oraz dodatnim wynikiem testu na obecność DNA HPV było 
poddane prospektywnej obserwacji. U wszystkich noworodków zbadano wymazy z nosogardzieli w kierunku DNA 
HPV. U wszystkich kobiet wykonano konwencjonalną ocenę rozmazów cytologicznych w systemie Bethesda 2011 
oraz oznaczono stężenie białka ostrej fazy w surowicy krwi (CRP).
Wyniki: Średnie stężenie CRP w surowicy ciężarnych wynosiło 11,6083 (SD- 12,93). Najczęstsze rozpoznania 
cytologiczne obejmowały ASCUS, n=13 (43,3%), LSIL -  n=10 (33,3%), HSIL -  n=5 (16,7%) i AGC- n=2 (6,7%). 
Obecność LR HPV DNA wykryto u 9 (30,0%) noworodków a obecność HR HPV DNA u 7 (23,3%) noworodków. U 
14 (46,7%) noworodków nie stwierdzono obecności DNA HPV.
Wnioski: Zakażenie HPV (incydentalne i/lub przewlekłe) obserwuje się u około 22% ciężarnych w województwie 
małopolskim. Zakażenie HPV noworodków stwierdzane jest u 53,3% HPV- dodatnich ciężarnych. Stężenie CRP>10 
mg/dl w surowicy ciężarnych w statystycznie istotny sposób (p 0,001) redukuje ryzyko zakażenia wertykalnego 
z HPV-dodatnich kobiet na płód.
Słowa kluczowe: HPV ciąża / noworodek transmisja wertykalna CRP
Introduction
Human papillomavirus (HPV) is the most common sexually 
transmitted infection. It is the leading causative agent of  abnormal 
Pap smears results, and it has been confirmed to be the necessary 
agent of  cervical carcinogenesis, leading through different stages 
of  cervical intraepithelial neoplasia (CIN) to cervical cancer 
(both, squamous and adenoid type).
Up to now, more than 200 HPV genotypes have been 
identified, out of  which approximately 40 have the affinity to 
affect the epithelia of  the lower genital tract. A steadily growing 
amount of  data links the maj ority of  cancers within the oropharynx 
to HPV infection [1-5].
Data reporting vertical transmission of  HPV from the mother 
to the fetus are inconsistent and scant [6-8]. Vertical transmission 
may occur by hematogenic route (transplacental), or by ascending 
contamination, or through the birth canal, which may result in 
the dreaded and rare laryngeal papillomatosis. Infected sperm at 
fertilization is a potential route of  infection, too.
The extent and risk factors of  HPV infections in infants 
remain ambiguous. Few meta-analyses to date have shown that 
vertical transmission developed in neonates born to infected 
mothers [6,7]. The rate of  vertical transmission reaches up to 80% 
[8-10]. It is also interesting which risk factors are associated with 
vertical transmission in HPV-positive pregnant women.
Objectives
The obj ective of  the study was to evaluate the rate of  vertical 
transmission of  HPV from HPV-positive pregnant women to their 
newborn infants, as well as to investigate the risk factors of HPV 
vertical transmission.
Material and methods
The clinical material was provided by 136 pregnant women, 
aged 18-45 years, referred to the outpatient colposcopy clinic 
of  the University Hospital in Krakow due to abnormal Pap test 
results. Out of  this group, 30 (22.05%) women with abnormal 
Pap test and positive DNA HPV test were prospectively observed. 
An informed consent was obtained from all subj ects and the 
Bioethical Commission of  the Jagiellonian University Medical 
College approved of  the study.
Obstetric data, i.e. pregnancy length, mode of  delivery 
(vaginal vs. Cesarean section), neonatal weight, and sex were 
obtained from all participants.
Demographic-environmental data, including place of  
residence (countryside vs. town), history of  contraceptive pill, 
tobacco, and alcohol use, as well as CRP levels, were collected 
as well.
Neonatal status, namely -  DNA HPV from the nasopharyngeal 
smear, was recorded in all infants during the perinatal period.
The conventional Pap test was performed with the cervix 
brush in all women. The Bethesda 2011 classification system was 
applied.
Colposcopy was performed in all women with the Olympus 
OCS-500 colposcope set, using terminology of  IFCPC 2011 (The 
International Federation of  Colposcopy and Cervical Pathology) 
identifying types of  transformation zones, i.e. TZ1, TZ2, TZ3. 
Colposcopically directed biopsy after delivery alongside a 
histopathological evaluation of  the cervical specimen was 
performed in all women.
The CRP serum level was analyzed in all pregnant women.
The material for DNA HPV analysis was sampled from the
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cervix of  the pregnant women and the nasopharyngeal mucosa of  
their neonates.
Linear Array HPV genotyping test
The LA HPV genotyping test (Roche Molecular Systems, 
Inc., Branchburg, NJ) is a new qualitative in vitro test for 
determination of  37 anogenital HPV DNA genotypes (Table 
(Table1).1). The LA test was applied to all samples that tested 
positive for HPV by DEIA and to 20 randomly selected DEIA- 
negative samples. (i) PCR amplification of HPV DNA.
The LA test uses biotinylated PGMY primers to amplify a 
450-bp fragment within the polymorphic L1 region of  the HPV 
genome. The PGMY amplification system has been described 
previously [13]. The PGMY primers are present in the “master 
mixture” (containing buffer, nucleotides [dATP, dCTP, dGTP, and 
dUTP], MgCl2, and <0.02% AmpliTaq Gold DNA polymerase) 
and they amplify HPV DNA from 3 7 HPV genotypes, including 13 
high-risk types (Table (Table1).1). Amplicons incorporate dUTP, 
allowing the use of  AmpErase enzyme (uracil N-glycosylase), 
which is included in the master mixture to prevent PCR carryover 
contamination. Capture probe sequences are located in the 
polymorphic regions of  L1 bound by these primers. An additional 
primer pair targets the human P-globin gene (268-bp amplicon) to 
provide control for cell adequacy, extraction, and amplification.
PCR was performed in a final reaction volume of  100 pl, 
containing 50 pl HPV master mixture, 40 pl PCR water, and 10 pl 
isolated DNA. The mixture was incubated for 2 min. at 50°C and 
for 9 min. at 95°C, followed by 40 cycles of  30 seconds at 95°C, 
1 min. at 55°C, and 1 min. at 72°C, with a final extension at 72°C 
lasting from 10 min. to a maximum of  1 h. The provided HPV- 
positive and HPV-negative controls were used with each set of  10 
samples to assess the performance of  the reaction [11].
Results
Study population
Mean age of  the examined women was 30.97 years (Std Dev. 
7.073), median 31.50. Mean number of  pregnancies per woman 
was 2.53 (Std Dev -0.819), median 3.0. Twenty-three (76.7%) 
women reported smoking before conception, while 7 (23.3%) 
have never smoked cigarettes. Thirteen (43.3%) reported regular
alcohol intake before conception, while 17 (56.7%) did not drink 
regularly before conception. Twenty-four (80%) women admitted 
to taking oral contraceptive pills for longer than three years, 
whereas 6 (20%) women did not take any oral contraceptive pills. 
Fifteen (50%) women lived in a city (Kraków) and 15 (50%) 
were residents of  the rural areas. An average C Reactive Protein 
(CRP) concentration in the studied pregnant women was 11.6083 
(Std Dev. 12.93). The most frequent cytological diagnoses of  
the cervical smears in the examined women were: ASCU: n=13 
(43.3%), LSIL: n=10 (33.3%), HSIL: n=5 (16.7%), and AGC: 
n=2 (6.7%).
DNA of  low risk HPV types- LR within the cervix was found 
in 17 (56.7%), co-existence of  DNA of  low risk- LR and high risk 
HPV types -  HR was observed in 8 (26.6%) and the presence of  
DNA of  high risk HPV types -  HR was reported in 5 (16.7%) 
women. Unsatisfactory colposcopic images (TZ3) were obtained 
in 3 (10%) gravidas, while satisfactory colposcopic images in 27 
(90%) women, among them TZ1 and TZ2 in 13 (43.3%) and in 
14 (46.7%) cases, respectively. The results of  histopathological 
examinations of  the targeted specimen collected under the control 
of  colposcopy in the post-partum period showed normal pattern 
of  the stratified squamous epithelium and glandular epithelium of  
the cervix, as well as the border of  the squamous and glandular 
epithelia in 10 (33.3%), koilocytosis in 9 (30%), CIN1 in 5 
(16.6%), CIN2 in 4 (13.3%) and CIN3 in 2 cases (6.6%).
Mean birth weight of  the children was 3386 grams (Std Dev. 
523.039). Average length of  pregnancy was 38.80 weeks (Std 
Dev. 1.472). In terms of  sex, 14 (46.7%) females and 16 (53.3%) 
males were delivered. Sixteen (53.3%) and 14 (46.7%) women 
had vaginal deliveries and cesarean sections, respectively.
In the neonates, the presence of  LR HPV DNA was detected 
in 9 (30.0%) and HR HPV DNA in 7 (23.3%) cases.
14 neonates (46.7%) tested negative for HPV DNA in the 
perinatal period.
In the univariate models, a significant correlation with 
vertical transmission of  HPV has been shown for the CRP 
variable, both, when broken down into categories as well as for the 
continuous variable. CRP>10 mg/dl, compared to the reference 
category >3.1 mg/dl, statistically significantly (OR=0.007 [95% 
CI: 0.000-0.125]) reduces the likelihood of HPV-HR or HPV-LR
Table I. Univariate logistic regression models.
V a ria b le S ig n if ic a n c e O R
9 5 %  c o n fid e n c e  in te rv a l
L o w e r  lim it U p p e r  lim it
Place of residence -  town 0.148 3.000 0.676 13.309
Age 0.814 0.988 0.891 1.095
Parity 0.057 2.847 0.971 8.344
Smoking (yes) 0.148 3.889 0.617 24.517
BCP history 3 years 0.999 3230949640.076 0.000
CRP (continuous variable) 0.013 0.668 0.487 0.917
CRP*
CRP (< 3.1 mg/l) 0.003
CRP (3.1-10 mg/l) 0.075 0.077 0.005 1.296
CRP (> 10 mg/dl) 0.001 0.007 0.000 0.125
6 7 4
* CRP (< 3.1 mg/dl) was adopted as the reference category.
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transmission. The odds ratio of  the vertical transmission of  HPV 
for the CRP variable (continuous) was OR=0.668 [95% CI: 0.487­
0.917]. Compared to the reference category >10 mg/dl, CRP<3.1 
mg/dl increases the likelihood of  HPV-LR transmission highly 
statistically significantly (OR=66 [95% CI: 3.472-1254.567]) 
as compared with no transmission. However, a wide confidence 
interval of  the obtained result should be noted and taken into 
consideration. The odds ratio was OR = 0.711 [95% CI: 0.524­
0.965].
Statistical analysis
The data were presented as means, medians, standard 
deviations, minimum values, maximum values and skewness.
Univariate logistic regression, multivariate logistic 
regression (forward selection method) and polynomial logistic 
regression were used in the analysis.
The level of  significance a = 0.05 was adopted in the 
analyses. The data were analyzed using the SPSS 20 package.
Discussion
HPV infection is the most commonly diagnosed sexually 
transmitted disease. Its aftermaths in the form of  intraepithelial 
neoplasia and cervical cancer lead to high morbidity and mortality, 
as well as perinatal complication [12]. It is also an emotional 
burden for women, especially gravidas, which results in lower 
quality of  life [13]. Although HPV infection is usually a transient, 
self-limiting phenomenon in pregnant women and in the general 
population of  young women, detection of  the DNA of  HPV 
viruses of  high oncogenic potential may favor the development 
of  a persistent infection, i.e. the most important risk factor for 
the development of  intraepithelial neoplasia and cervical cancer.
According to numerous reports of  various authors, the 
incidence of  HPV infection in the population of  pregnant women 
amounts to 30% and is higher than in their non-pregnant peers 
[14, 15]. According to epidemiological studies and observations 
of  other authors, HPV types detected most often during 
pregnancy include: 16, 18, 31, 33, 35 and HPV 6 and 11 [16, 17]. 
Pregnancy-related reduced T-cell immune response and hormonal 
changes affecting cellular response of  the immune system, as 
well as the role of  the GRE sequence of  the HPV genome that 
takes advantage of  changes in a woman’s hormonal management 
during pregnancy through its analogy with the glucocorticoid 
receptor, may explain this epidemiological observation.
Most studies on vertical transmission of  HPV infection from 
the mother to the fetus available in the literature comprise cohorts 
of  pregnant women [4,6,7, 8, 9,10]. The novel aim of  this paper is 
an attempt to estimate risk factors of  such transmission in women 
already infected with HPV and showing cytological abnormalities 
in their cervical smears. In our study, the percentage of  neonates 
with detected HPV DNA was 53.3% (30.0% and 23.3% for LR 
and HR types, respectively). These observations are consistent 
with the findings of  other authors [7, 14, 15, 17, 18]. Although 
the above-cited findings of  other authors suggest that the risk of  
vertical transmission is relatively low in the general population 
of  pregnant women, it increases if  HPV infection in a mother 
is accompanied by an abnormal cytological examination result 
(especially HSIL and AGC), as our research has shown. Cellular 
lesions induced by HPV do not appear until after the infection 
(from 12 weeks to 2-3 years) and have a positive correlation
with the so-called viral load in the cell. The logistic regression 
model conducted in this analysis has shown that risk factors for 
the vertical transmission of  HPV infection from mother to fetus 
are: number of  pregnancies greater than or equal to 3, habitual 
smoking, and use of  oral hormonal contraception for more 
than three years. These observations are consistent with the 
epidemiological observations on risk factors for HPV infection 
and development of  intraepithelial neoplasia of  the cervix [19, 
20, 21, 22, 23]. We have demonstrated in the same analysis that 
inflammation in the body of  a pregnant woman defined by CRP 
level is related to the vertical transmission of  HPV infection in 
the inversely proportional manner. Serum CRP level in pregnant 
women > 10 mg/dl statistically significantly (p=0.001) reduces 
this risk. Knowing the pathophysiology of  the HPV infection as 
well as the idea of  immune tolerance developing in pregnancy, 
one may speculate that inflammation in a pregnant woman 
triggers non-specific mechanisms which limit the proportion of  
HPV transmission from the mother to the fetus. This interesting 
observation requires further investigation and validation in larger 
prospective clinical trials.
Conclusion
HPV infection (incidental or chronic) is observed in 
approximately 22% of  pregnant women from the population of  
the Małopolska province.
Neonatal HPV infection in HPV-positive women was noted 
in 53.3% of  subj ects.
CRP concentration >10 mg/dl in the serum of  pregnant 
women statistically significantly (p=0.001) reduces the risk of  
vertical transmission of HPV from the mother to the fetus.
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